References

Arici, O.F. and N. Cetin, 2011. Protective role of ghrelin against carbon tetrachloride (CCl₄)-induced coagulation disturbances in rats. Regul. Pept., 166: 139-142.
CrossRef  |  PubMed  |  Direct Link  |  

Chang, L., J. Zhao, G.Z. Li, B. Geng, C.S. Pan, Y.F. Qi and CS. Tang, 2004. Ghrelin protects myocardium from isoproterenol-induced injury in rats. Acta Pharmacol. Sin., 25: 1131-1137.
PubMed  |  

Chang, L., R. Yongsheng, L. Xiuhua, L.W. Gen and Y. Jinghui et al., 2001. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J. Cardiovasc. Pharm., 43: 165-170.
PubMed  |  

Doroshow, J.H., G.Y. Locker and C.E. Myers, 1980. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin. J. Clin. Invest., 65: 125-128.
CrossRef  |  PubMed  |  

El Eter, E., A. Al Tuwaijiri, H. Hagar and M. Arafa, 2007. In vivo and in vitro antioxidant activity of ghrelin: Attenuation of gastric ischemic injury in the rat. J. Gastroenterol. Hepatol., 22: 1791-1799.
CrossRef  |  Direct Link  |  

Evans, L.M., J.S. Davies, R.A. Anderson, G.R. Ellis and S.K. Jackson et al., 2000. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur. J. Endocrinol., 142: 254-262.
PubMed  |  

Freedman, R.A., K.P. Anderson, L.S. Green and J.W. Mason, 1987. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am. J. Cardiol., 59: 168-169.

Gustafson, D.L., J.D. Swanson and C.A. Pritsos, 1993. Modulation of glutathione and glutathione dependent antioxidant enzymes in mouse heart following doxorubicin therapy. Free Radic. Res. Commun., 19: 111-120.
PubMed  |  

Iseri, S.O., G. Sener, M. Yuksel, G. Contuk, S. Cetinel, N. Gedik and B.C. Yegen, 2005. Ghrelin against alendronate-induced gastric damage in rats. J. Endocrinol., 187: 399-406.
PubMed  |  

Jordan, W.H., R.A. Byrd, R.L. Cochrane, G.K. Hanasono and J.A. Hoyt et al., 1993. A review of the toxicology of the antibiotic MICOTIL 300. Vet. Human. Toxicol., 35: 151-158.
PubMed  |  

Kart, A., K. Yapar, M. Karapehlivan and M. Citil, 2007. The Possible Protective effect of L-carnitine on tilmicosin-induced cardiotoxicity in mice. J. Vet. Med. A, 54: 144-146.
CrossRef  |  

Kart, A., M. Karapehlivan, K. Yapar, M. Citil and A. Akpinar, 2007. Protection through L-carnitine on tissue oxidant status and sialic acid content in tilmicosin-induced alterations in BALB/c mice. Acta. Vet. Brno., 76: 203-207.
CrossRef  |  

Kaul, N., N. Siveski-Iliskovic, M. Hill, J. Slezak and P.K. Singal, 1993. Free radicals and the heart. J. Pharmacol. Toxicol. Methods, 30: 55-67.
CrossRef  |  

Kawczynska-Drozdz, A., R. Olszanecki, J. Jawien, T. Brzozowski, W.W. Pawlik, R. Korbut and T.J. Guzik, 2006. Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats. Am. J. Hypertens., 19: 764-767.
PubMed  |  

Kheradmand, A., M. Alirezaei, P. Asadian, E.R. Alavi and S. Joorabi, 2009. Antioxidant enzyme activity and MDA level in the rat testis following chronic administration of ghrelin. Andrologia, 41: 335-340.
CrossRef  |  

Kojima, M., H. Hosoda, Y. Date, M. Nakazato, H. Matsuo and K. Kangawa, 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402: 656-660.
CrossRef  |  PubMed  |  Direct Link  |  

Leite-Moreira, A.F. and J.B. Soares, 2007. Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discovery Today, 12: 276-288.
CrossRef  |  

Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275.
CrossRef  |  PubMed  |  Direct Link  |  

Main, B.W., J.R. Means, L.E. Rinkema, W.C. Smith and R.D. Sarazan, 1996. Cardiovascular effects of the macrolide antibiotic tilmicosin, administered alone and in combination with propranolol or dobutamine, in conscious unrestrained dogs. J. Vet. Pharmacol. Ther., 19: 225-232.
PubMed  |  

McKay, S.G., D.W. Morck, J.K. Merrill, M.E. Olson, S.C. Chan and K.M. Pap, 1996. Use of tilmicosin for treatment of pasteurellosis in rabbits. Am. J. Vet. Res., 57: 1180-1184.
PubMed  |  

Modric, S., A.I. Webb and H. Derendorf, 1998. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. J. Vet. Pharmacol. Therap., 21: 444-452.
CrossRef  |  

Modric, S., A.I. Webb and M. Davidson, 1999. Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats. Lab. Anim. Sci., 49: 248-253.
PubMed  |  

Nagaya, N., M. Uematsu, M. Kojima, Y. Ikeda and F. Yoshihara et al., 2001. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation, 104: 1430-1435.
PubMed  |  

Obay, B.D., E. Tasdemir, C. Tumer, H.M. Bilgin and M. Atmaca, 2008. Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model. Peptides, 29: 448-455.
CrossRef  |  Direct Link  |  

Rao, P.S., M.V. Cohen and H.S. Mueller, 1983. Production of free radicals and lipid peroxides in early experimental myocardial ischemia. J. Mol. Cell. Cardiol., 15: 713-716.
CrossRef  |  

Singal, P.K., N. Khaper, V. Palace and D. Kumar, 1998. The role of oxidative stress in the genesis of heart disease. Cardiovasc. Res., 40: 426-432.
PubMed  |  

Takaya, K., H. Ariyasu, N. Kanamoto, H. Iwakura and A. Yoshimoto et al., 2000. Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab., 85: 4908-4911.
CrossRef  |  

Tamargo, J., B. de Miguel and M.T. Tejerina, 1982. A comparison of Josamycin with macrolides and related antibiotics on isolated rat atria. Eur. J. Pharmacol., 80: 285-293.
CrossRef  |  

Tritos, N.A. and E.G. Kokkotou, 2006. The physiology and potential clinical applications of ghrelin, a novel peptide hormone. Mayo. Clin. Proc., 81: 653-660.
PubMed  |  

Yada, T., H. Kaiya, K. Mutoh, T. Azuma, S. Hyodo and K. Kangawa, 2006. Ghrelin stimulates phagocytosis and superoxide production in fish leukocytes. J. Endocrinol., 189: 57-65.
PubMed  |  

Yapar, K., A. Kart, M. Karapehlivan, 2006. Effects of different doses of tilmicosin on some biochemical parameters and antioxidant status in serum and cardiac tissues in mice. Bull. Vet. Inst. Pulawy, 50: 605-608.

Yazar, E., V. Altunok, M. Elmas, B. Tras, A.L. Bas and V. Ozdemir, 2002. The effect of tilmicosin on cardiac superoxide dismutase and glutathione peroxidase activities. J. Vet. Med. B, 49: 209-210.
CrossRef  |  Direct Link  |  

Yoshioka, T., K. Kawada, T. Shimada and M. Mori, 1979. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am. J. Obstet. Gynecol., 135: 372-376.
CrossRef  |  PubMed  |  Direct Link  |  

Zwirska-Korczala, K., M. Adamczyk-Sowa, P. Sowa, K. Pilc and R. Suchanek et al., 2007. Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism. J. Physiol. Pharmacol., 58: 53-64.
PubMed  |